We acknowledge funding support from the Japan Society for the Promotion of Science (KAKENHI-Grants to K.N [26893261]), Okinaka Memorial Institute for Medical Research (to KN), and Japanese Ministry of Health, Labour and Welfare (to TN); Mrs. Kohichi Kamata and Atsushi Seyama at the Department of Pathology in the Saitama Medical University International Medical Center for their excellent assistance in histochemical and immunohistochemical staining; as well as Dr. Celso E. Gomez-Sanchez for providing the mouse monoclonal CYP11B2 antibody and rat monoclonal CYP11B1 antibody.

This study was approved by the Institutional Review Boards of Saitama Medical University International Medical Center and Yokohama Rosai Hospital (approval #: 16-093 and 26-38, respectively). Written consent was obtained from all patients prior to the procedure.
1. Patient Preparation
<ol>
	<li>Set the patient on the examination bed.</li>
	<li>Place a venous line in an upper arm (or left leg) for the administration of medication during the procedure.</li>
	<li>Insert the access sheath into the right femoral vein after appropriate skin disinfection and local anesthesia.</li>
	<li>Collect a blood sample (1 mL) from the right femoral vein (peripheral blood sample before the administration of cosyntropin).</li>
</ol>
2. Catheterization
<ol>
	<li>ssAVS of right adrenal TVs
	<ol>
		<li>Insert either the catheter with the MK Adrenal-R shape (Figure 1A and 1B) or the catheter with the MK X shape (Figure 1C) into the right adrenal vein (RAV) as previously reported 15,16, collect a blood sample (1 mL), and remove the catheter (right cAVS sample before the administration of cosyntropin). Use the micro-catheter if needed.</li>
		<li>Select an appropriate parent catheter for the right adrenal: When the &#34;long diameter of the IVC&#34; is shorter than 25 mm, use MK Adrenal-R. Otherwise, use MK X.</li>
		<li>Re-shape the parent catheter if needed.
		<ol>
			<li>Based on CT images, re-shape the width of the selected catheter (red bidirectional arrows in Figure 1A or 1C) to fit the &#34;long diameter of the IVC&#34;15 (also see Case #1) and the angle of the catheter tip to fit the &#34;modified transverse angle of the RAV&#34;15 (also see Case #1).</li>
			<li>Re-shape the catheter while applying high temperature steam from boiled water (e.g. electronic kettle) to the catheters. Detailed procedures are described elsewhere15.</li>
		</ol>
		</li>
		<li>Place the tip of the parent catheter into the RAV with an appropriate angle (average modified transverse angle of the RAV: 123.6 &#176;)15 and depth (1 - 2 mm). 
		NOTE: Accurate parent catheter placement is essential for delivery of the micro-catheter into the target TV.</li>
		<li>Manipulate the parent catheter to change the direction of the catheter tip to aim for one of the right TVs, and insert a saline-filled micro-catheter with a guidewire. 
		NOTE: Pushing and pulling the parent catheter will change the vertical angle of the parent catheter, i.e. when the 3D-type catheter is pulled toward the foot, the catheter tip is directed upwards, whereas the catheter tip is directed downwards when the catheter is pushed (see Case #1 below). Once the tip of catheter is inserted into the RAV exit with an appropriate angle and depth, the micro-catheter may be inserted. It is important for the examiner to prevent a patient from breathing deeply or the vertical angle may change. The micro-catheter described above is inserted with a guidewire into a TV.</li>
		<li>Perform venography using digital subtraction angiography through the micro-catheter with a small amount of saline-diluted (1:1) contrast-medium (0.1 - 0.3 mL; iopromide injection) and flush it gently. Collect a 1-mL blood sample slowly for the measurement of plasma aldosterone concentrations (PAC) and plasma cortisol concentrations (PCC).</li>
		<li>Pull the micro-catheter slightly back, and flush the micro-catheter line with at least 0.5 mL of saline. Aim the parent catheter tip at the next TV.</li>
		<li>Repeat steps 2.1.6 and 2.1.7 above for all right TVs.</li>
	</ol>
	</li>
	<li>ssAVS of left adrenal TVs
	<ol>
		<li>Insert an L shape catheter (Figure 2) into the left adrenal vein (LAV), collect a blood sample (1 mL), and remove the catheter (left cAVS sample before the administration of cosyntropin). Use the micro-catheter.</li>
		<li>Place the parent catheter. 
		NOTE: Anatomically, the left adrenal central vein is confluent with the inferior phrenic vein, and venous blood in these veins flows into LAV8. Therefore, to only collect venous blood samples from left adrenal tissues, catheterization into the left adrenal central vein is needed, i.e., catheterization into the point before merging with the inferior phrenic vein, which typically requires micro-catheterization, even for cAVS. While performing adrenal central venography, similar to the right side, it is important to identify left adrenal TVs, particularly lateral TV (see &#34;Case #2 as an example of LAV-ssAVS&#34;). A catheter with the L shape was preferred for use. Portions #1, #2, and #3 (Figure 2) of the catheter fit the IVC, renal vein, as well as common trunk of the inferior phrenic vein and LAV, respectively, thereby allowing portion #3 to stably sit in the common trunk.</li>
		<li>Insert the micro-catheter into left adrenal TVs and collect blood samples from left TVs. See Steps 2.1.5 - 2.1.6 above for right adrenal TVs for general procedures. 
		NOTE: The micro-catheter and guidewire (the same as those in the right ssAVS) are inserted into TVs (typically the superior-median, superior-lateral, and lateral TVs) as described in Case #2 below, and blood samples are collected.</li>
	</ol>
	</li>
</ol>
3. After Injections
<ol>
	<li>Inject 200 &#181;g of synthetic adrenocorticotropic hormone (cosyntropin, bolus) through the venous line followed by the continuous administration of cosyntropin at a rate of 50 &#181;g/min.</li>
	<li>Fifteen minutes after the bolus cosyntropin injection, perform cAVS again, as described above, and ssAVS, as described in steps 2.1 and 2.2. Collect 1 mL blood each.</li>
	<li>Collect a blood sample from the right femoral vein.</li>
	<li>Remove all catheters and access sheath, and complete the cAVS and ssAVS examinations after astriction. 
	NOTE: Regarding details on the general adrenal venous sampling technique (steps except for 3.2), refer to other textbooks or journals17.</li>
</ol>

<ol>
	<li>Funder, J. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+Management+of+Primary+Aldosteronism:+Case+Detection,+Diagnosis,+and+Treatment:+An+Endocrine+Society+Clinical+Practice+Guideline.">The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.</a> J Clin Endocrinol Metab. 101 (5), 1889-1916 (2016).</li><li>Akehi, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Proposed+diagnostic+criteria+for+subclinical+Cushing's+syndrome+associated+with+adrenal+incidentaloma.">Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.</a> Endocr J. 60 (7), 903-912 (2013).</li><li>Choi, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=K++channel+mutations+in+adrenal+aldosterone-producing+adenomas+and+hereditary+hypertension.">K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.</a> Science. 331 (6018), 768-772 (2011).</li><li>Beuschlein, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Somatic+mutations+in+ATP1A1+and+ATP2B3+lead+to+aldosterone-producing+adenomas+and+secondary+hypertension.">Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.</a> Nat Genet. 45 (4), 440-444 (2013).</li><li>Scholl, U. I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Somatic+and+germline+CACNA1D+calcium+channel+mutations+in+aldosterone-producing+adenomas+and+primary+aldosteronism.">Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.</a> Nat Genet. 45 (9), 1050-1054 (2013).</li><li>Azizan, E. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Somatic+mutations+in+ATP1A1+and+CACNA1D+underlie+a+common+subtype+of+adrenal+hypertension.">Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.</a> Nat Genet. 45 (9), 1055-1060 (2013).</li><li>Tamura, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Somatic+KCNJ5+mutation+occurring+early+in+adrenal+development+may+cause+a+novel+form+of+juvenile+primary+aldosteronism.">Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism.</a> Mol Cell Endocrinol. 441, 134-139 (2017).</li><li>McLachlan, M. S., Roberts, E. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Demonstration+of+the+normal+adrenal+gland+by+venography+and+gas+insufflation.">Demonstration of the normal adrenal gland by venography and gas insufflation.</a> Br J Radiol. 44 (525), 664-671 (1971).</li><li>Nishikawa, T., Matsuzawa, Y., Saito, J., Omura, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Is+it+Possible+to+Extirpate+Cardiovascular+Events+in+Primary+Aldosteronism+After+Surgical+Treatment.">Is it Possible to Extirpate Cardiovascular Events in Primary Aldosteronism After Surgical Treatment.</a> Jpn Clin Med. 1, 21-23 (2010).</li><li>Nishikawa, T., Matsuzawa, Y., Saito, J., Omura, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Super-selective+ACTH-stimulated+adrenal+venous+sampling+can+simply+differentiated+bilateral+adrenal+hyperplasia+from+bilateral+adenomas+in+primary+aldosteronism.">Super-selective ACTH-stimulated adrenal venous sampling can simply differentiated bilateral adrenal hyperplasia from bilateral adenomas in primary aldosteronism.</a> , 35-36 (2009).</li><li>Nishimoto, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Case+Report:+Nodule+Development+From+Subcapsular+Aldosterone-Producing+Cell+Clusters+Causes+Hyperaldosteronism.">Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.</a> J Clin Endocrinol Metab. 101 (1), 6-9 (2016).</li><li>Miekos, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anatomical+basis+of+radiodiagnosis+of+the+adrenal+gland.">Anatomical basis of radiodiagnosis of the adrenal gland.</a> Int Urol Nephrol. 11 (3), 193-200 (1979).</li><li>Omura, M., Saito, J., Matsuzawa, Y., Nishikawa, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Supper-selective+ACTH-stimulated+adrenal+vein+sampling+is+necessary+for+detecting+precisely+functional+state+of+various+lesions+in+unilateral+and+bilateral+adrenal+disorders,+inducing+primary+aldosteronism+with+subclinical+Cushing's+syndrome.">Supper-selective ACTH-stimulated adrenal vein sampling is necessary for detecting precisely functional state of various lesions in unilateral and bilateral adrenal disorders, inducing primary aldosteronism with subclinical Cushing's syndrome.</a> Endocr J. 58 (10), 919-920 (2011).</li><li>Nishikawa, T., Omura, M., Saito, J., Matsuzawa, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Primary+aldosteronism:+comparison+between+guidelines+of+the+Japanese+and+the+US+Endocrine+Society.">Primary aldosteronism: comparison between guidelines of the Japanese and the US Endocrine Society.</a> Expert Rev. Endocrinol. Metab. 7 (6), 637-645 (2012).</li><li>Araki, T., Okada, H., Onishi, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Does+catheter+shape+influence+the+success+of+right+adrenal+venous+sampling?+The+interaction+of+catheter+shape+to+anatomical+factors+on+CT.">Does catheter shape influence the success of right adrenal venous sampling? The interaction of catheter shape to anatomical factors on CT.</a> Jpn J Radiol. 34 (11), 707-717 (2016).</li><li>Young, W. F., Stanson, A. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=What+are+the+keys+to+successful+adrenal+venous+sampling+(AVS)+in+patients+with+primary+aldosteronism?.">What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?.</a> Clin Endocrinol (Oxf). 70 (1), 14-17 (2009).</li><li>Harsha, A., Trerotola, S. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Technical+aspects+of+adrenal+vein+sampling.">Technical aspects of adrenal vein sampling.</a> J Vasc Interv Radiol. 26 (2), 239 (2015).</li><li>Nishikawa, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Guidelines+for+the+diagnosis+and+treatment+of+primary+aldosteronism--the+Japan+Endocrine+Society+2009.">Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.</a> Endocr J. 58 (9), 711-721 (2011).</li><li>Nishimoto, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Immunohistochemistry+of+aldosterone+synthase+leads+the+way+to+the+pathogenesis+of+primary+aldosteronism.">Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.</a> Mol Cell Endocrinol. , (2016).</li><li>Nishimoto, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Adrenocortical+zonation+in+humans+under+normal+and+pathological+conditions.">Adrenocortical zonation in humans under normal and pathological conditions.</a> J Clin Endocrinol Metab. 95 (5), 2296-2305 (2010).</li><li>Funder, J. W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Case+detection,+diagnosis,+and+treatment+of+patients+with+primary+aldosteronism:+an+endocrine+society+clinical+practice+guideline.">Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.</a> J Clin Endocrinol Metab. 93 (9), 3266-3281 (2008).</li><li>Heitzer, E., Auer, M., Ulz, P., Geigl, J. B., Speicher, M. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Circulating+tumor+cells+and+DNA+as+liquid+biopsies.">Circulating tumor cells and DNA as liquid biopsies.</a> Genome Med. 5 (8), 73 (2013).</li><li>Alix-Panabieres, C., Pantel, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinical+Applications+of+Circulating+Tumor+Cells+and+Circulating+Tumor+DNA+as+Liquid+Biopsy.">Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.</a> Cancer Discov. 6 (5), 479-491 (2016).</li><li>Pinzani, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Detection+of+circulating+tumor+cells+in+patients+with+adrenocortical+carcinoma:+a+monocentric+preliminary+study.">Detection of circulating tumor cells in patients with adrenocortical carcinoma: a monocentric preliminary study.</a> J Clin Endocrinol Metab. 98 (9), 3731-3738 (2013).</li><li>Pantel, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Circulating+epithelial+cells+in+patients+with+benign+colon+diseases.">Circulating epithelial cells in patients with benign colon diseases.</a> Clin Chem. 58 (5), 936-940 (2012).</li><li>Chiu, L. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Identification+of+differentially+expressed+microRNAs+in+human+hepatocellular+adenoma+associated+with+type+I+glycogen+storage+disease:+a+potential+utility+as+biomarkers.">Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.</a> J Gastroenterol. 49 (8), 1274-1284 (2014).</li><li>Nishimoto, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Aldosterone-stimulating+somatic+gene+mutations+are+common+in+normal+adrenal+glands.">Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.</a> Proc Natl Acad Sci U S A. 112 (33), E4591-E4599 (2015).</li></ol>

The authors have nothing to disclose.

The ssAVS technique with representative case outcomes were described herein. Cases #1 - 2 and Case #3 were surgically and medically treated based on ssAVS results, respectively. Moreover, the results obtained for Cases #1 - 3 indicated that steroid hormone concentrations in ssAVS samples clearly reflect the hormonal activity of upstream adrenal tissues, particularly tumors, presumably because tumor blood outflow is directly obtained. The ssAVS method may play an invaluable role in identifying the affected adrenal segments from bilateral adrenocortical lesions (e.g., Cases #1 - 2), in definitive diagnoses of IHA (e.g., Case #3), and in basic science research to elucidate the pathophysiologies of adrenocortical diseases and discover novel biomarkers for these diseases as discussed below.
The guidelines for PA1,18,21 recommend performing cAVS to identify a unilateral adrenal lesion of PA by calculating the lateralized ratio ([higher PAC/PCC] / [lower PAC/PCC]). However, this calculation may result in a misdiagnosis when cortisol-producing lesions co-exist. The probable cortisol-producing adenoma in Case #2 clearly produced excessive amounts of cortisol in the right adrenal, and cortisol production in the left adrenal was suppressed. It is important to note that many APAs also produce excessive amounts of cortisol because they often express both CYP11B2 and CYP11B120. Another limitation of the lateralized ratio in cAVS is that it cannot distinguish bilateral APAs from idiopathic hyperaldosteronism (e.g., Case #3).
Furthermore, ssAVS blood samples may significantly contribute to the advancement of hormone excess disease research and treatments. For example, the ssAVS blood directory collected from adenoma may contain high concentrations of circulating tumor cells and their DNA22,23. Previous studies reported that the liquid biopsy method is clinically useful for distinguishing adrenocortical carcinoma from adenoma24 and for the diagnosis of benign adenoma diseases25,26. In order to prove this concept, current attempts are being made to detect APA-associated mutations including KCNJ5 using ssAVS samples and a high performance next generation sequencer7,11,19,27, which may contribute to future APA treatments. Liquid-biopsied cells may also provide researchers with the opportunity to perform molecular analyses on IHA, which is currently not possible because the disease cannot be treated surgically. In addition to the liquid biopsy method, pure tumor outflow samples may be useful for metabolomics study to identify novel steroid biomarkers.
The critical technical steps of ssAVS method are to: (i) Identify each tributary vein during central adrenal venography. (ii) during venography, use a small amount of contrast medium (0.1 - 0.3 mL) and flush it gently to avoid adrenal hemorrhage. (iii) Advance the guidewire gently and without too much force to avoid penetrating tributary veins. (iv) Terminate the method immediately when adrenal hemorrhage occurs or is suspected.
The selection of a parent catheter is also critical for the success of ssAVS. Regarding cAVS of the RAV, Araki et al. recently reported the usefulness of a three-dimensional (3D)-type catheter with a 3D shape15. A catheter with the R shape (Figure 1A and 1B) and a catheter with the X shape (Figure 1C) are available as 3D-type catheters for ssAVS. Araki et al. analyzed several anatomical parameters based on CT findings with regards to the success rate of 3D-type catheters15. In univariate analyses (i) a shorter &#34;short diameter of the inferior vena cava (IVC)&#34; (ii) larger &#34;ratio of the long diameter to short diameter of the IVC&#34; (iii) smaller &#34;transverse angle of the RAV&#34; (iv) smaller &#34;modified transverse angle of the RAV&#34;, and (v) smaller &#34;vertical angle of the RAV&#34; correlated with the success rate in the RAV. In a multivariate analysis, only (iv) a smaller &#34;modified transverse angle of the RAV&#34; was an independent predictor of successful RAV catheterization. They concluded that the findings of the multivariate analysis may be due to the stability of the catheter in the IVC; namely, the width of 3D-type catheters (red bidirectional arrow in Figure 1A and 1C) fits well in the &#34;long diameter of the IVC&#34;, thereby stabilizing these catheters. Overall, when the &#34;long diameter of the IVC&#34; is shorter than 25 mm, use MK Adrenal-R, otherwise MK X.
Overall, the significance of ssAVS is: (i) its contribution to the advancement of hormone excess disease research (ii) its promotion of partial adrenalectomy by isolating a hormone-producing lesion to the level of an adrenal segment (see Case #1) (iii) its promotion of the assessment of cortisol excesses by collecting pure adrenal efflux (see Case #2) (iv) its detection of actual idiopathic hyperaldosteronism (see Case #3) (v) its contribution to advancing the development of novel therapies, which may include trans-venous segmental ablation of the adrenals. Thus, if performed as described herein, any angiographer may successfully perform the ssAVS protocol in addition to cAVS and contribute to the advancement of research on and the treatment of adrenal hormonal excess diseases.
ssAVS with cAVS are routinely performed at Yokohama Rosai Hospital and Saitama Medical University for PA patients. Between October 2014 and September 2015, two angiographers (KM and SM) performed ssAVS on 125 cases (78 and 47 cases, respectively) with a 100 % success rate and within a reasonable time (58 - 130 min) without adrenal rupture or thrombosis that required surgery. In this method, an additional cost is incurred for the micro-catheter (10-fold more expensive in Japan than the conventional catheter) and PAC/PCC measurements of tributary samples. However, considering the clinical and scientific benefits of the procedure, the additional cost is justified, at least in industrialized countries. One marginal limitation of ssAVS and bilateral adrenalectomy is that it may not cure bilateral lesions and follow-up assessments are needed, which includes the evaluation of PA recurrence (see Case #1). However, this is also true for unilateral PA cases. Consequently, these results indicate that any angiographer has the ability to perform ssAVS with a high success rate by following the protocol provided in this video article. In order to promote the ssAVS method worldwide, hands-on training is always provided at Yokohama Rosai Hospital and Saitama Medical University. Please feel free to contact these institutions if you are interested in this method.

Primary aldosteronism (PA) and subclinical Cushing&#39;s syndrome (SCS) are conditions in which the adrenal glands autonomously produce excess amounts of aldosterone and cortisol, respectively. In adults, PA is mainly caused by an aldosterone-producing adenoma (APA) or idiopathic hyperaldosteronism (IHA)1, whereas SCS is mainly caused by a cortisol-producing adenoma2. Somatic mutations in ion channel/pump genes, including potassium channel, inwardly rectifying subfamily J, member 5 (KCNJ5), have been identified in APAs, and are associated with autonomous aldosterone production3,4,5,6. Familial hyperaldosteronism types 1 - 3 are rare types of PA, and type 3 is caused by a KCNJ5 germ-line mutation3. A case of a novel type of juvenile PA, which was presumably due to the genetic mosaicism of normal and KCNJ5 mutant adrenocortical cells, was recently identified7. In the juvenile PA case, the adrenal cortices consisted of a normal portion and hyperplastic aldosterone-producing lesions, with the normal portion being identified by the novel &#39;super-selective&#39; adrenal venous sampling (ssAVS, also called segmental adrenal venous sampling) method described herein. The ssAVS method allowed this bilateral PA patient to be treated surgically by bilateral adrenalectomy while sparing the normal portion7.
Adrenal venous sampling was initially reported in 19718 when computed tomography (CT) had not yet been developed. In &#34;conventional&#34; adrenal venous sampling (cAVS), a catheter is inserted into both adrenal central veins, from which blood samples are collected. Thus, cAVS is only useful for judging the laterality of PA and not for identifying surgical options for bilateral PA. Drs. Masao Omura and Kohzoh Makita (authors of this article) in Yokohama Rosai Hospital developed the ssAVS method in order to investigate additional surgical treatment options for PA7,8,9,10,11, which may also be useful for SCS, as described in Case #2 (see Representative Results).
In ssAVS, blood samples are collected from small adrenal tributary veins (TVs: smaller upstream branches of the adrenal central veins) using a specialized split-tip micro-catheter9. The right and left adrenals typically have three tributary veins each, i.e., the superior, lateral, and inferior TVs in the right adrenal as well as the superior-median, superior-lateral, and lateral TVs in the left adrenal. Very few connections have been identified between these TVs12. Therefore, ssAVS enables the identification of a specific adrenal segment(s) not producing aldosterone autonomously within an affected adrenal, thereby allowing bilateral adrenal surgery to be performed on bilateral PA while sparing unaffected adrenal segment(s). Furthermore, the ssAVS method is applicable to investigations on the pathophysiology of novel types of PA such as juvenile PA (described above7) and bilateral APA13,14. Since it is critical for the treatment of bilateral PAs and the elucidation of their pathogenesis, which may include &#34;idiopathic&#34; hyperaldosteronism, ssAVS is recommended worldwide, and, hence, a detailed description of the method involved was provided herein.

<table><tbody><tr><td>CX-Catheter EII with the MK Adrenal-R shape</td><td>Silux co.</td><td>GA-E5F-MK1-60S</td><td>3D catheter for right adrenal venous sampling</td></tr><tr><td>CX-Catheter EII with the MK X shape</td><td>Silux co.</td><td>GA-E5F [MK-X] 60S</td><td>3D catheter for right adrenal venous sampling</td></tr><tr><td>Aqua V3 guidewire</td><td>Formec co.</td><td>HS8616H</td><td>guidewire for the micro-catheter</td></tr><tr><td>Gold Crest Micro-Catheter</td><td>Goldcrest Medic Inc.</td><td>KCV29S1S-OM</td><td>micro-catheter for superselective adrenal venous sampling</td></tr><tr><td>CX catheter-UII with the MK ADRENAL-L shape</td><td>Silux co.</td><td>GA-US5F [MK-3] B65S</td><td>3D catheter for left adrenal venous sampling</td></tr></tbody></table>

a novel method: super-selective adrenal venous sampling

Primary aldosteronism (PA) and subclinical Cushing&#39;s syndrome (SCS) are conditions in which the adrenal glands autonomously produce excessive amounts of aldosterone and cortisol, respectively. The conventional adrenal venous sampling (cAVS) method collects blood samples from both adrenal central veins and is useful for identifying the laterality of excess hormone production in a unilateral lesion(s), as documented in PA cases. In cAVS, plasma cortisol concentrations (PCCs) are used to normalize plasma aldosterone concentrations (PACs). A novel &#34;super-selective&#34; adrenal venous sampling (ssAVS) method was developed using a micro-catheter, which collects blood samples from adrenal tributary veins (TVs). PACs in ssAVS samples do not require PCC normalization because samples contain a limited amount of systemic venous blood, if any. The ssAVS method enabled segmental lesion(s) to be detected in both adrenal glands, which may be treated by bilateral adrenalectomy, thereby sparing lesion-free segment(s). Right and left adrenals typically have three TVs each, i.e., the superior, lateral, and inferior TVs in the right adrenal as well as the superior-median, superior-lateral, and lateral TVs in the left adrenal. In the ssAVS method, specific parent catheters and a technique to handle them are required, and have been described herein. Furthermore, ssAVS results from three cases of PA are presented: bilateral aldosterone-producing adenoma (APA) (Case #1), left APA and right possible cortisol-producing adenoma causing SCS (Case #2), and idiopathic hyperaldosteronism in which bilateral adrenal segments produced excessive amounts of aldosterone (Case #3). The ssAVS method is not difficult for expert angiographers, and, thus, is recommended worldwide to treat PA cases for which cAVS does not represent a viable surgical treatment option.

Case #1 (YRPA #3472)
Case #1 was a 46-year-old female. When she was 33 years old, she was hospitalized in a local hospital for severe hypertension with hypokalemia (serum K 1.8 [normal range: 3.5 - 5.9] mEq/L). She was diagnosed with PA based on blood test results (PAC 320 [35.7 - 240] pg/mL, PRA &#60;0.1 [0.3 - 2.9] ng/mL/h). CT indicated bilateral adrenocortical adenoma (data not available). After cAVS (data not available), she underwent left adrenalectomy, but her PA persisted. Thirteen years after the first surgery (46 years old), she was referred to Yokohama Rosai Hospital for an evaluation of PA. A physical examination was normal, except for a high body mass index (29.3 [&#60;25] kg/m2). Laboratory tests were normal, except for very high PAC (1490 pg/mL) and very low serum K (2.2 mEq/L). Her PAC was very high (2,550 [cut-off: &#60;60] pg/mL) even 4 hours after a 2-L infusion of saline (saline infusion test), suggesting that she had severe PA. An abdominal CT scan revealed a 22-mm right adrenal tumor (Figure 3A).
cAVS and ssAVS were performed under a stimulation with synthetic adrenocorticotropic hormone (ACTH). Based on CT, the &#34;long diameter of the IVC&#34; (the length of the red dotted line in Figure 3A) and &#34;modified transverse angle of the RAV&#34; (the larger angle between the red and blue dotted lines in Figure 3A) were 28 mm and 145 degrees, respectively. The &#34;width&#34; and &#34;tip angle&#34; of the catheter with the X shape (Figure 1C) were pre-operatively re-shaped to fit the IVC and RAV, as detailed in reference15. Catheterization into the exit of the RAV was quickly performed without any difficulty. Right adrenal venography demonstrated that the lateral TV was significantly expanded (pink arrowhead in Figure 3B) at the point at which its branches outlined the shape of the tumor, suggesting that a large volume of blood was flowing out from the adenoma into this TV. A micro-catheter was inserted and a blood sample was collected from the lateral TV after confirming its venography (Figure 3C). By pulling and pushing the catheter, the micro-catheter was easily inserted into the superior and inferior TVs for venography (Figure 3D and 3E), and this was followed by sampling.
PAC in the central vein and lateral TV were very high (422,000 pg/mL and 588,000 pg/mL, respectively; normal range &#60; 14,000 pg/mL for both18), suggesting that the tumor was an APA (Figure 3C, Table 1). PAC in the superior and inferior TVs were 8,230 pg/mL and 12,600 pg/mL, respectively (Figure 3D and 3E), indicating that these TVs were collecting blood from the normal adrenal tissues. PCC levels in the central vein, superior TV, lateral TV, and inferior TV were similar (1,110 &#181;g/dL, 1,150 &#181;g/dL, 1,050 &#181;g/dL, and 1,080 &#181;g/dL, respectively), suggesting that cortisol production was uniform throughout the adrenal cortex including the tumor-bearing part. Thus, PAC/PCC values, which are generally used for data analyses in cAVS, were consistent with PAC values in cAVS and ssAVS in this case. She underwent partial adrenalectomy sparing the normal portion. A pathological examination identified adrenocortical adenoma (T in Figure 3F), which expressed aldosterone synthase (CYP11B2) in many cells (T in Figure 3G) and steroid 11&#946;-hydroxylase (CYP11B1, cortisol-synthesizing enzyme) in a small number of cells (T in Figure 3H), which confirmed the diagnosis of APA19,20. In the adjacent normal adrenal, although CYP11B2 was not expressed in the zona glomerulosa, which may have been due to low circulating renin, CYP11B1 was expressed in the zona fasciculata and zona reticularis (N in Figure 3H), suggesting that cortisol production was normal. These pathological results of APA and suppressed CYP11B2 expression in adjacent normal adrenal tissue were consistent with the ssAVS results (Table 1). After surgery, her blood pressure (114/62 mmHg) as well as PAC and PRA in her peripheral blood (52 pg/mL and 0.8 ng/mL/h, respectively) normalized without any antihypertensive drugs.
Case #2 (YRPA #4119)
Case #2 was a 59 year-old male with hypertension since he was 45 years old. CT during a routine physical examination incidentally identified bilateral adrenal nodules, which were enhanced by contrast medium (Figure 4A). He was referred to Yokohama Rosai Hospital for the further evaluation of hypertension and adrenal nodules. A physical examination was normal without apparent Cushingoid features. Blood tests were normal including PCC (7.6 [6.2 - 18.0] &#181;g/dL), ACTH (20.8 [7.2 - 63.3] pg/mL), and PAC (201 pg/mL), except for PRA (&#60;0.2 ng/mL/h) and serum K (3.0 mEq/L). The saline infusion test showed high PAC (374 pg/mL). PCC at 11 pm and after the overnight administration of 1 mg of dexamethasone were 6.8 and 7.2 (cut-off: &#8804;5 and &#8804;1.8) &#181;g/dL, respectively. Thus, he was diagnosed with PA with SCS2,18.
In order to identify which tumor was responsible for excess hormone production, cAVS with ssAVS was performed under a synthetic ACTH stimulation. Left adrenal venography using the micro-catheter through the catheter with the L shape (Figure 2) identified the typical superior-median (yellow arrowhead in Figure 4B), superior-lateral (red arrowhead), and lateral TVs (pink arrowhead). The superior-median TV had a short filling defect, presumably due to the adenoma (green arrows in Figure 4B). It is noteworthy that the head of the micro-catheter (black arrowhead in Figure 4B) was placed inside the adrenal central vein before merging with the inferior phrenic vein, thereby enabling unobstructed imaging of the lateral TV. Following the guidewire, the micro-catheter was inserted into the superior-median (venography is not available) and superior-lateral (Figure 4C) TVs for venography and sample collection. The lateral TV merged perpendicularly with the central vein, which was a typical finding. The tip of the micro-catheter and its guidewire were bended and inserted into the lateral TV, and a blood sample was collected. As described in Case #1, cAVS from RAV and ssAVS from right superior TV (red arrowhead in Figure 4E), lateral TV (pink arrowhead) downstream of the tumor, and inferior TV (yellow arrowhead) were also performed.
In data analyses of cAVS and ssAVS, PAC and PCC values were utilized, but not PAC/PCC values because PCC values markedly varied among the right and left TVs (median and interquartile range: 99.6 and 70.3 - 577.5 &#181;g/dL, respectively, Table 1). PAC in the left adrenal central vein was high (94,800 [&#60;14,000] pg/mL), and that in the left superior-median TV was very high (304,000 pg/mL: 3.2-fold that in the central vein), suggesting that the left adrenal tumor was the lesion responsible for PA. However, PAC in left superior-lateral and lateral TVs were low (2,060 and 2,240 pg/mL, respectively), suggesting that they collect blood from non-tumor portions. PCC in the left central vein, superior-median TV, superior-lateral TV, and lateral TV (74.7 &#181;g/dL, 87.1 &#181;g/dL, 75.7 &#181;g/dL, and 54.1 &#181;g/dL, respectively) were markedly lower than those in Case #1, suggesting that cortisol production was suppressed throughout the left adrenal cortex including the tumor due to excess cortisol production from the right adrenal gland, as described below. Regarding the right adrenal, PAC in the right central vein (5,190 pg/mL, i.e., within the normal range of &#60;14,000) and lateral TV (5,300 pg/mL) were higher than those in the superior and inferior TVs (1,710 and 2,180 pg/mL, respectively), which suggested that the right tumor produced a small amount of aldosterone. PCC in the right lateral TV (1,050 &#181;g/dL) was markedly higher than those in the right superior TV (112 &#181;g/dL), right inferior TV (420 &#181;g/dL), and left TVs, suggesting that the right adrenal tumor produced excessive amounts of cortisol (i.e. cortisol-producing adenoma) and caused SCS. In order to treat PA, the patient underwent right partial adrenalectomy, which normalized his hypertension (136/82 mmHg without anti-hypertensives) and PAC (50 pg/mL) 3 days after surgery. A pathological examination identified an adrenocortical adenoma (T in Figure 4F) that expressed CYP11B2 (T in Figure 4G), but not CYP11B1 (T in Figure 4H), confirming the diagnosis of APA. The adjacent normal adrenal did not express CYP11B1 (N in Figure 4H), suggesting that cortisol production was suppressed due to the probable cortisol-producing adenoma on the opposite side. These pathological results of adenoma and adjacent adrenal tissue were consistent with the ssAVS results (Table 1). SCS is currently being followed-up without treatment because it has not caused hypertension or impaired glucose tolerance2.
Overall, in Cases #1 and #2, the ssAVS method clearly indicated segmental adrenal hormone production, not only for aldosterone, but for cortisol, and enabled these patients to be treated by surgery.
Case #3 (YRPA #8243)
Case #3 was a 50-year-old female with dizziness due to severe hypertension since she was 48 years old. A high PAC to PRA ratio ([131 pg/mL] / [0.3 ng/mL/h] = 436.7, [cut-off: &#60;200]18) suggested that she had PA. She was referred to Yokohama Rosai Hospital for further evaluations of hypertension. A physical examination was normal with a normal body mass index (23.4 kg/m2). Blood tests were normal including PAC (183 pg/mL) and PRA (0.4 ng/mL/h). The saline infusion test showed slightly high PAC (66 [cut-off: &#60;60] pg/mL)18, suggesting that she had mild PA. A high PAC to PRA ratio ([146 pg/mL] / [0.4 ng/mL/h] = 365 [cut-off: &#60; 200]) after the administration of captopril confirmed that she had PA (captopril challenge test)18. CT detected no apparent adrenal adenoma (Figure 5A). In order to identify aldosterone-producing adrenal segment(s), cAVS with ssAVS was performed under a synthetic ACTH stimulation. In cAVS, PAC/PCC in the right and left central veins were ([57,600 pg/mL] / [901 &#181;g/dL] = 63.9) and ([18,000 pg/mL] / [389 &#181;g/dL] = 46.3), respectively, suggesting that she had bilateral PA (lateralized ratio = 1.4, cut-off: &#60;2.618, Table 1). In right ssAVS, PAC in the superior TV (#1 in Figure 5B), superior-median TV (#2), lateral TV (#3), and inferior TV (#4) were 59,100 pg/mL, 66,400 pg/mL, 57,300 pg/mL, and 45,400 pg/mL, respectively. In left ssAVS, PAC in the superior-median TV (#1 in Figure 5C), superior-lateral TV (#2), lateral TV (#3), and inferior TV (#4) were 43,900 pg/mL, 19,600 pg/mL, 23,000 pg/mL, and 36,900 pg/mL, respectively. Thus, PAC were higher than 14,000 pg/mL throughout bilateral TVs, suggesting that Case #3 was true IHA. She is currently being treated with a mineralocorticoid receptor antagonist.
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/55716/55716fig1.jpg" /> 
Figure 1: Catheters used for Right cAVS. (A and B) Frontal and lateral views of the catheter with the R shape, respectively. (C) A frontal view of the catheter with the X shape. Lengths indicated by bidirectional arrows in Figure 1A and 1C fit the &#34;long diameter of the IVC&#34;15 for cAVS. <a href="http://cloudflare.jove.com/files/ftp_upload/55716/55716fig1large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/55716/55716fig2.jpg" /> 
Figure 2: Catheter used for Left cAVS. A frontal view of the catheter with the L shape. Portions #1, #2, and #3 in the figure fit the IVC, renal vein, and common trunk of the inferior phrenic vein and LAV, respectively, letting portion #3 stably sit in the common trunk. <a href="http://cloudflare.jove.com/files/ftp_upload/55716/55716fig2large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/55716/55716fig3v4.jpg" /> 
Figure 3: CT, Venography in ssAVS, Histology of Removed Adrenal of Case #1. (A) Contrast-enhanced CT. The length of the red dotted line indicates the &#34;long diameter of the IVC&#34;15. The larger angle between the red and blue dotted lines indicates the &#34;modified transverse angle of the RAV&#34;15. IVC, inferior vena cava; Ao, aorta; kid, kidney; T, tumor. (B) Right adrenal venography. Red, yellow, and pink arrowheads indicate superior, lateral, and inferior TVs, respectively. (C, D, and E) venography images of lateral (lat.), superior (sup.), and inferior (inf.) TVs, respectively. Black dots pointed by pink, red, and yellow arrowheads indicate micro-catheter heads. (F) Hematoxylin and eosin staining of the removed adrenocortical tumor (T) and adjacent adrenal gland (N). (G and H) Immunohistochemistry for aldosterone synthase (CYP11B2: abbreviated as B2 in the figure) and steroid 11&#946;-hydroxylase (CYP11B1: B1) on serial sections of that in Figure 3F. Scale bars in A and F - H indicate 1 cm and 1 mm, respectively. <a href="http://cloudflare.jove.com/files/ftp_upload/55716/55716fig3large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" class="xfigimg" src="/files/ftp_upload/55716/55716fig4.jpg" /> 
Figure 4: CT, Venography in ssAVS, Histology of Removed Adrenal of Case #2. (A) Contrast-enhanced CT. IVC, inferior vena cava; Ao, aorta; Lt. T: left adrenocortical tumor; Rt. T: right adrenocortical tumor. (B) Left adrenal venography. Yellow, red, and pink arrowheads indicate the superior-median, superior-lateral, and lateral TVs, respectively. Venography was performed using a micro-catheter, and its head is indicated by a black arrowhead. Green arrows indicate a short filling defect presumably due to the adenoma. (C and D) Venography images of the superior-lateral (sup. - lat.) and lateral (lat.) TVs, respectively. Red and pink arrowheads indicate micro-catheter heads (black dots in Figures 4C and 4D, respectively). It is noteworthy that the same colored arrowheads in Figure 4B and Figures 4C - 4D indicate the same portion of TVs, although venography of the superior-median TV, indicated by the yellow arrowhead in Figure 4B, was not available. (F) Hematoxylin and eosin staining of the removed adrenocortical tumor (T) and adjacent adrenal gland (N). (G and H) Immunohistochemistry for aldosterone synthase (CYP11B2: abbreviated as B2 in the figure) and steroid 11&#946;-hydroxylase (CYP11B1: B1) on serial sections of that in Figure 4F. Scale bars in A and F - H indicate 1 cm and 0.5 mm, respectively. <a href="http://cloudflare.jove.com/files/ftp_upload/55716/55716fig4large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 5" class="xfigimg" src="/files/ftp_upload/55716/55716fig5.jpg" /> 
Figure 5: CT and Venography in ssAVS of Case #3. (A) Contrast-enhanced CT. Rt. and Lt indicate adrenal glands. (B) right adrenal venography. Numbers 1, 2, 3, and 4 with red arrows indicate the superior, superior-median, lateral, and inferior TVs. (C) Left adrenal venography. Numbers 1, 2, 3, and 4 with red arrows indicate the superior-median, superior-lateral, superior-lateral, and superior-lateral TVs. Scale bar = 1 cm (A). <a href="http://cloudflare.jove.com/files/ftp_upload/55716/55716fig5large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Table 1" src="/files/ftp_upload/55716/55716table1v2.jpg" /> 
Table 1: cAVS and ssAVS Data of Cases #1 - 3. <a href="http://cloudflare.jove.com/files/ftp_upload/55716/55716table1v2large.jpg" target="_blank">Please click here to view a larger version of this table.</a>

Watch this Scientific Journal Video about A Novel Method: Super-selective Adrenal Venous Sampling at JoVE.com

A Novel Method: Super-selective Adrenal Venous Sampling

&#39;Super-selective&#39; adrenal venous sampling (ssAVS, also called segmental adrenal venous sampling: sAVS)&#160;was performed using a micro-catheter to identify adrenal segment(s) that produce excessive amounts of hormones. The ssAVS technique was described, cases in which adrenal segmental lesion(s) were identified by ssAVS were presented, and the usefulness of ssAVS in future adrenal research was discussed.

Primary aldosteronism (PA) and subclinical Cushing&#39;s syndrome (SCS) are conditions in which the adrenal glands autonomously produce excessive amounts ...

a-novel-method-super-selective-adrenal-venous-sampling

Research

JoVE Journal

Medicine

23.3K Views.  Nerima Hikarigaoka Hospital. 'Super selectieve' bijnier veneuze bemonstering (ssAVS, ook wel genoemd per segment, adrenal veneuze bemonstering: bespaard) werd uitgevoerd met behulp van een micro-katheter te identificeren bijnier segmenten de betreffende bedrijfsactiviteit die grote hoeveelheden hormonen produceren. De ssAVS techniek werd beschreven, gevallen waarin bijnier segmentale lesion(s) werden geïdentificeerd door ssAVS werden gepresenteerd, en het nut van de ssAVS in toekomstige bijnier onde...

Video: A Novel Method: Super-selective Adrenal Venous Sampling

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

The extraction and analysis of catecholamine neurotransmitters in biological fluids is of great importance in assessing nervous system function and related diseases, but their precise measurement is still a challenge. Many protocols have been described for neurotransmitter measurement by a variety of instruments, including high-pressure liquid chromatography (HPLC). However, there are shortcomings, such as complicated operation or hard-to-detect multiple targets, which cannot be avoided, and presently, the dominant analysis technique is still HPLC coupled with sensitive electrochemical or fluorimetric detection, due to its high sensitivity and good selectivity. Here, a detailed protocol is described for the pretreatment and detection of catecholamines with high pressure liquid chromatography with electrochemical detection (HPLC-ECD) in real urine samples of infants, using electrospun composite nanofibers composed of polymeric crown ether with polystyrene as adsorbent, also known as the packed-fiber solid phase extraction (PFSPE) method. We show how urine samples can be easily precleaned by a nanofiber-packed solid phase column, and how the analytes in the sample can be rapidly enriched, desorbed, and detected on an ECD system. PFSPE greatly simplifies the pretreatment procedures for biological samples, allowing for decreased time, expense, and reduction of the loss of targets. 
Overall, this work illustrates a simple and convenient protocol for solid-phase extraction coupled to an HPLC-ECD system for simultaneous determination of three monoamine neurotransmitters (norepinephrine (NE), epinephrine (E), dopamine (DA)) and two of their metabolites (3-methoxy-4-hydroxyphenylglycol (MHPG) and 3,4-dihydroxy-phenylacetic acid (DOPAC)) in infants' urine. The established protocol was applied to assess the differences of urinary catecholamines and their metabolites between high-risk infants with perinatal brain damage and healthy controls. Comparative analysis revealed a significant difference in urinary MHPG between the two groups, indicating that the catecholamine metabolites may be an important candidate marker for early diagnosis of cases at risk for brain damage in infants.

We present a convenient solid-phase extraction coupled to high-pressure liquid chromatography (HPLC) with electrochemical detection (ECD) for simultaneous determination of three monoamine neurotransmitters and two of their metabolites in infants' urine. We also identify the metabolite MHPG as a potential biomarker for the early diagnosis of brain damage for infants.

The extraction and analysis of catecholamine neurotransmitters in biological fluids is of great importance in assessing nervous system function and ...

Chemistry

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Metastasis is a complex process, requiring cells to overcome barriers that are only incompletely modeled by in vitro assays. A systematic workflow was established using robust, reproducible in vivo models and standardized methods to identify novel players in melanoma metastasis. This approach allows for data inference at specific experimental stages to precisely characterize a gene's role in metastasis. Models are established by introducing genetically modified melanoma cells via intracardiac, intradermal, or subcutaneous injections into mice, followed by monitoring with serial in vivo imaging. Once preestablished endpoints are reached, primary tumors and/or metastases-bearing organs are harvested and processed for various analyses. Tumor cells can be sorted and subjected to any of several 'omics' platforms, including single-cell RNA sequencing. Organs undergo imaging and immunohistopathological analyses to quantify the overall burden of metastases and map their specific anatomic location. This optimized pipeline, including standardized protocols for engraftment, monitoring, tissue harvesting, processing, and analysis, can be adopted for patient-derived, short-term cultures and established human and murine cell lines of various solid cancer types.

This article describes a workflow of techniques employed for testing novel candidate mediators of melanoma metastasis and their mechanism(s) of action.

Metastasis is a complex process, requiring cells to overcome barriers that are only incompletely modeled by in vitro assays. A systematic workflow was ...

Cancer Research

Exploring Metabolite Exchange in Brown Adipose Tissue

Arteriovenous Metabolomics to Measure In Vivo Metabolite Exchange in Brown Adipose Tissue

Brown adipose tissue (BAT) plays a crucial role in regulating metabolic homeostasis through a unique energy expenditure process known as non-shivering thermogenesis. To achieve this, BAT utilizes a diverse menu of circulating nutrients to support its high metabolic demand. Additionally, BAT secretes metabolite-derived bioactive factors that can serve as either metabolic fuels or signaling molecules, facilitating BAT-mediated intratissue and/or intertissue communication. This suggests that BAT actively participates in systemic metabolite exchange, an interesting feature that is beginning to be explored. Here, we introduce a protocol for in vivo mouse-level optimized BAT arteriovenous metabolomics. The protocol focuses on relevant methods for thermogenic stimulations and an arteriovenous blood sampling technique using Sulzer's vein, which selectively drains interscapular BAT-derived venous blood and systemic arterial blood. Next, a gas chromatography-based metabolomics protocol using those blood samples is demonstrated. The use of this technique should expand the understanding of BAT-regulated metabolite exchange at the inter-organ level by measuring the net uptake and release of metabolites by BAT.

Author Spotlight: Illuminating New Avenues for Adipose Tissue Metabolism and Disease Prevention 

In this protocol, methods relevant for BAT-optimized arteriovenous metabolomics using GC-MS in a mouse model are outlined. These methods allow for the acquisition of valuable insights into BAT-mediated metabolite exchange at the organismal level.

Brown adipose tissue (BAT) plays a crucial role in regulating metabolic homeostasis through a unique energy expenditure process known as non-shivering ...

Biochemistry

Subclavian Vein Puncture As an Alternative Method of Blood Sample Collection in Rats

Blood collection with enough blood volume is essential in animal experiments. Blood collection from the tail vein of rats is popular and less stressful compared to other more aggressive methods such as retro-orbital plexus sample collection. However, this blood collection method is sometimes limited by an unsatisfactory success rate. Here, we introduce a method for blood collection through the subclavian vein puncture. The subclavian vein is located just under the clavicle and this vein is large enough to fulfill the volume requirements of blood collection. Our results show that this method is safe and applicable for blood collection sampling with the required blood volume. Blood collection through the subclavian vein puncture could serve as an alternative blood collection method in case of failed tail vein blood sampling in rats.

Here, we present a protocol to collect blood samples from the rat subclavian vein.

Blood collection with enough blood volume is essential in animal experiments. Blood collection from the tail vein of rats is popular and less stressful ...

Improved Blood Sampling Technique to Assess Gut Microbial Metabolites in Mice

Sequential Blood Collection from Inferior Vena Cava Followed by Portal Vein to Evaluate Gut Microbial Metabolites in Mice

Gut microbial products are known to act both locally within the intestine and get absorbed into circulation, where their effects can extend to numerous distant organ systems. Short-chain fatty acids (SCFA) are one class of metabolites produced by gut microbes during the fermentation of indigestible dietary fiber. They are now recognized&#160;as important contributors to how the gut microbiome influences extra-intestinal organ systems via the gut-lung, gut-brain, and other gut-organ axes throughout the host. SCFAs are absorbed from the colon, through intestinal tissue,&#160;into the portal vein (PV). They then pass through the liver, and are consumed in various organs such as the brain, muscle, adipose tissue, and lungs. SCFAs are most easily measured in the expelled fecal material however, more accurate measurements have been obtained from intra-colonic fecal contents. Here we propose that sampling PV and systemic circulating plasma of a single subject may be preferable for studying the&#160;absorption, transport, and systemic levels of SCFAs in mice. We present a new technique for efficient blood sampling from the PV and inferior vena cava (IVC) that allows for the collection of relatively large volumes of blood from the portal and systemic circulations. This is accomplished by ligating the PV, thereby allowing&#160;for the dilation or enlargement of the PV as it backfills from the mesenteric veins that drain into it. Using this method, we were able to improve the rate of successful collection as well as the total amount of blood collected (up to 0.3 mL from IVC and 0.5 mL from PV).

Author Spotlight: Gut Microbiome-Lung Tissue Communication Through Short-Chain Fatty Acid Analysis

The protocol demonstrates a method to collect blood from portal veins and inferior vena cava from mice sequentially to evaluate the production and absorption of gut microbial metabolites.

Gut microbial products are known to act both locally within the intestine and get absorbed into circulation, where their effects can extend to numerous ...

Immunology and Infection

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Adrenal activity can be assessed in the equine species by analysis of feces for corticosterone metabolites. During a potentially aversive situation, corticotrophin releasing hormone (CRH) is released from the hypothalamus in the brain. This stimulates the release of adrenocorticotrophic hormone (ACTH) from the pituitary gland, which in turn stimulates release of glucocorticoids from the adrenal gland. In horses the glucocorticoid corticosterone is responsible for several adaptations needed to support equine flight behaviour and subsequent removal from the aversive situation. Corticosterone metabolites can be detected in the feces of horses and assessment offers a non-invasive option to evaluate long term patterns of adrenal activity. Fecal assessment offers advantages over other techniques that monitor adrenal activity including blood plasma and saliva analysis. The non-invasive nature of the method avoids sampling stress which can confound results. It also allows the opportunity for repeated sampling over time and is ideal for studies in free ranging horses. This protocol describes the enzyme linked immunoassay (EIA) used to assess feces for corticosterone, in addition to the associated biochemical validation.

Adrenal activity can be assessed in the equine species by analysis of feces for corticosterone metabolites. The method offers a non-invasive option to assess long term patterns in both domestic and free ranging horses. This protocol describes the enzyme linked immunoassay involved and the associated biochemical validation.

Adrenal activity can be assessed in the equine species by analysis of feces for corticosterone metabolites. During a potentially aversive situation, ...

Biology

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug

Blood sampling in small laboratory animals is necessary for pharmaceutical lead optimization but can cause great harm and stress to experimental animals, which could potentially affect results. The jugular vein cannulation (JVC) in rats is a widely used model for repeated blood collection but requires adequate training of surgery skills and animal care. This article details the microsurgical procedures for establishing and maintaining a permanent JVC rat model with specific focus on the placement and sealing of the jugular cannula. The importance of monitoring physiological (e.g., body weight, food, and water intake) and hematological parameters, was highlighted with results presented for 6 days post-surgery during the rat&#39;s recovery. The drug-plasma concentration-time profile of orally administered natural phenol ellagic acid was determined in the JVC rat model.

Detailed microsurgical techniques are demonstrated to establish a longer-term jugular vein cannulation rat model for sequential blood collection in the same animal. Physiological and hematological parameters have been monitored during the rat's recovery phase. This model has been applied to study pharmacokinetics of orally administered polyphenol without inducing animal stress.

Blood sampling in small laboratory animals is necessary for pharmaceutical lead optimization but can cause great harm and stress to experimental animals, ...

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

We present the preliminary results of a longitudinal observational study aimed at evaluating the effectiveness and safety at different short- and long-term follow-ups of vascular occlusion of the great saphenous vein (GSV) and small saphenous vein (SSV) affected by severe pathological reflux, using an innovative modified cyanoacrylate surgical glue composed of N-butyl cyanoacrylate and methacryloxy sulfolane (NBCA+MS). Ninety patients, prospectively recruited for 1 year, underwent the study with EcoColor-Doppler (ECD) to evaluate the maximum diameters of the GSV and SSV in the orthostatic position and the reflux time (RT). An RT greater than 0.5 s was considered pathologic. Clinical, etiology, anatomy, and pathophysiology (CEAP) assessment was used for the complete evaluation of each patient in the study. All the patients were treated by NBCA+MS glue to obtain vein occlusion and observed before treatment (baseline; T0), within 6 h after treatment (T1), 1 month after treatment (T2), 3 months after treatment (T3), 6 months after treatment (T4), and 1 year after treatment (T5). Chi-square (&#967;) analysis was performed to evaluate the effectiveness and safety of the treatment. All the patients participated in the entire duration of the study. Complete occlusion was maintained in 100% of patients at T1, 98.9% at T2 and T3, and 97.8% at T4 and T5 (p &lt; 0.001). None of the patients suffered from post-surgical thrombosis. No blue hyperpigmentation, or paresthesia was observed during the entire observation period. Immediately after treatment, 7.7% of patients needed painkillers; 1 week after treatment, 100% of patients returned to normal life. Vascular occlusion of the great or small saphenous vein using NBCA+MS glue is a safe procedure with persistent benefits after a 1 year follow-up. This procedure can be performed with local anesthesia, allowing a quick return to normal life. Thanks to its low invasiveness, the treatment is not painful.

Here, we present a protocol to treat the great saphenous vein (GSV) and the small saphenous vein (SSV) affected by severe pathological reflux, using an original sclerosing and embolizing cyanoacrylate-based glue composed of N-butyl cyanoacrylate and methacryloxy sulfolane (NBCA+MS).

We present the preliminary results of a longitudinal observational study aimed at evaluating the effectiveness and safety at different short- and ...

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

The hormone which the adrenal cortex secretes is vital for animals against stress and diseases. The method described here is the procedure of primary cultured rat adrenal cells and related functional assays (immunofluorescence staining of lipid droplet surface protein, as well as corticosterone analysis). Unlike an in vivo model, the variation of interexperiments in adrenal monolayer cultures is less and the experimental condition is easy to control. Besides, the source of rats is also more stable than other animals, like bovine ones. There are also several human adrenal cell lines (NCI-H295, NCI-H295R, SW13, etc.) that can be used in adrenal studies. However, the steroid production of these lines will still be influenced by numerous factors, which include serum lot number, passage number, mutant/loss of distinct genes, etc. Except for lacking 17&#945;-hydroxylase, the primary culture of rat adrenocortical cells is a better and more convenient technique for studying adrenal physiology. In summary, primary rat adrenal cultures could be a good in vitro platform for researchers to investigate the mechanisms of the reagent of interest in the adrenal gland system.

The hormone secreted by the adrenal cortex is vital for animals against stress and diseases. Here, we present a protocol to culture the primary rat adrenal cells. It could be a good in vitro platform for investigating the mechanisms of the reagent of interest in adrenal steroidogenesis and lipid biosynthesis.

The hormone which the adrenal cortex secretes is vital for animals against stress and diseases. The method described here is the procedure of primary ...

Subclavian Vein Puncture Method for Repeated Blood Collection in Conscious Rats

Subclavian Vein Blood Sampling in Conscious Rats

There are several established methods for obtaining repeated blood samples from rats, with the most commonly employed methods being lateral tail vein sampling without anesthesia and jugular vein sampling with anesthesia. However, most of these methods require assistance and anesthetic equipment and sometimes pose difficulties in terms of blood collection or the poor quality of blood samples. In addition, these methods of blood collection consume significant time and human resources when repeated blood sampling is required for a large number of rats. This study presents a technique for repetitive blood sampling in non-anesthetized rats by a single proficient individual. Highly satisfactory blood samples can be obtained by puncturing the subclavian vein. The method demonstrated an impressive overall success rate of 95%, with a median time of merely 2 min from rat restraint to the completion of blood collection. Furthermore, performing consecutive blood collections within the designated range does not inflict any harm on the rats. This method is worth promoting for blood collection, especially in large-scale pharmacokinetic studies.

Author Spotlight: Developing an Efficient Blood Collection Method in Non-Anesthetized Rats 

Here we present a combination of effective rat restriction and subclavian vein puncture methods that enable rapid, safe, and repeated blood collection in rats without anesthesia.

There are several established methods for obtaining repeated blood samples from rats, with the most commonly employed methods being lateral tail vein ...

A Novel Method: Super-selective Adrenal Venous Sampling

Samenvatting

Meer video's verkennen